Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-09

Clinical Trial Update: Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing teneofovir in late pregnancy to reduce vertical transmission of hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir (Tenofovir)

Snippet

Sponsor: New Discovery LLC | Conditions: Hepatitis B Infection, Chronic Infection | Phase 4 | Status: COMPLETED